SEC Form 3 · accession 0001209191-18-017869
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pui San Kwan
Officer — Principal Acctg Officer
Period of report
Mar 5, 2018
Accepted (ET)
Mar 7, 2018 · 8:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 18,749 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.94 | holding | — | — | — | — | Dec 31, 2022 | Common Stock | 25,000 | — | D |
| Stock Option (right to buy)F2 | $14.28 | holding | — | — | — | — | Jul 23, 2023 | Common Stock | 7,000 | — | D |
| Stock Option (right to buy)F3 | $6.08 | holding | — | — | — | — | Jan 2, 2024 | Common Stock | 30,000 | — | D |
| Stock Option (right to buy)F4 | $8.19 | holding | — | — | — | — | Feb 23, 2025 | Common Stock | 37,300 | — | D |
| Stock Option (right to buy)F5 | $3.57 | holding | — | — | — | — | Mar 7, 2026 | Common Stock | 40,000 | — | D |
| Stock Option (right to buy)F6 | $6.62 | holding | — | — | — | — | Feb 28, 2027 | Common Stock | 40,000 | — | D |
Explanation of responses
- F1The option was granted on December 31, 2012, and was fully vested prior to March 5, 2018.
- F2The option was granted on July 23, 2013, and was fully vested prior to March 5, 2018.
- F3The option was granted on January 2, 2014, and was fully vested prior to March 5, 2018.
- F4The option was granted on February 23, 2015. 25% of the total number of shares of common stock subject to the option vested on January 1, 2016, and 1/48th of the total number of shares of common stock subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- F5The option was granted on March 7, 2016. 25% of the total number of shares of common stock subject to the option vested on January 1, 2017, and 1/48th of the total number of shares of common stock subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- F6The option was granted on February 28, 2017. 25% of the total number of shares of common stock subject to the option vested on January 1, 2018, and 1/48th of the total number of shares of common stock subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Remarks
See Exhibit 24, Power of Attorney.